- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x DEB: 6-DEOXYERYTHRONOLIDE B(Non-covalent)
DEB.2: 17 residues within 4Å:- Chain A: M.83, F.84, L.94, M.178, L.179, I.243, A.244, T.248, V.291, S.295, F.296, L.396, I.397
- Ligands: HEM.1, RAM.3, FMT.12, FMT.13
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:M.83, A:F.84, A:L.94, A:L.179, A:A.244, A:T.248, A:V.291, A:L.396, A:I.397
- Water bridges: A:S.240
- 1 x RAM: alpha-L-rhamnopyranose(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 5 residues within 4Å:- Chain A: T.86, P.87, E.89, P.90, Q.193
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:P.87, A:E.89, A:Q.193, A:Q.193
GOL.6: 6 residues within 4Å:- Chain A: K.265, R.266, S.269, L.337, D.338, F.339
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.265, A:K.265, A:F.339
- Water bridges: A:L.337
- 63 x FMT: FORMIC ACID(Non-functional Binders)
FMT.7: 3 residues within 4Å:- Chain A: T.173, L.184
- Ligands: FMT.48
Ligand excluded by PLIPFMT.8: 4 residues within 4Å:- Chain A: D.97, P.98, P.99, D.100
Ligand excluded by PLIPFMT.9: 5 residues within 4Å:- Chain A: F.70, P.98, A.353, H.354
- Ligands: FMT.18
Ligand excluded by PLIPFMT.10: 4 residues within 4Å:- Chain A: R.191
- Ligands: FMT.38, FMT.48, FMT.68
Ligand excluded by PLIPFMT.11: 5 residues within 4Å:- Chain A: S.20, L.21, P.22, D.28, R.398
Ligand excluded by PLIPFMT.12: 8 residues within 4Å:- Chain A: P.88, E.89, G.92, A.95, F.296
- Ligands: DEB.2, RAM.3, FMT.13
Ligand excluded by PLIPFMT.13: 6 residues within 4Å:- Chain A: P.88, E.89, Q.193
- Ligands: DEB.2, RAM.3, FMT.12
Ligand excluded by PLIPFMT.14: 2 residues within 4Å:- Chain A: D.37, E.38
Ligand excluded by PLIPFMT.15: 5 residues within 4Å:- Chain A: E.38, S.41, R.42, W.53
- Ligands: FMT.40
Ligand excluded by PLIPFMT.16: 2 residues within 4Å:- Chain A: P.141, A.142
Ligand excluded by PLIPFMT.17: 4 residues within 4Å:- Chain A: V.145, V.150, R.172, E.401
Ligand excluded by PLIPFMT.18: 4 residues within 4Å:- Chain A: S.68, F.70, D.97
- Ligands: FMT.9
Ligand excluded by PLIPFMT.19: 4 residues within 4Å:- Chain A: R.35, R.326, D.327, E.328
Ligand excluded by PLIPFMT.20: 6 residues within 4Å:- Chain A: R.62, I.63, G.66, D.67, H.351
- Ligands: FMT.21
Ligand excluded by PLIPFMT.21: 4 residues within 4Å:- Chain A: G.66, D.67, S.68
- Ligands: FMT.20
Ligand excluded by PLIPFMT.22: 2 residues within 4Å:- Chain A: D.143, E.146
Ligand excluded by PLIPFMT.23: 5 residues within 4Å:- Chain A: F.349, H.355, R.363
- Ligands: FMT.44, FMT.50
Ligand excluded by PLIPFMT.24: 4 residues within 4Å:- Chain A: R.123, A.155, L.165
- Ligands: FMT.65
Ligand excluded by PLIPFMT.25: 3 residues within 4Å:- Chain A: P.8, P.10, R.42
Ligand excluded by PLIPFMT.26: 1 residues within 4Å:- Chain A: T.6
Ligand excluded by PLIPFMT.27: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.28: 3 residues within 4Å:- Chain A: M.58, R.62, V.330
Ligand excluded by PLIPFMT.29: 3 residues within 4Å:- Chain A: E.119
- Ligands: FMT.41, FMT.62
Ligand excluded by PLIPFMT.30: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.31: 4 residues within 4Å:- Chain A: E.89, Q.193, Q.194, M.197
Ligand excluded by PLIPFMT.32: 3 residues within 4Å:- Chain A: E.49, A.79, T.80
Ligand excluded by PLIPFMT.33: 5 residues within 4Å:- Chain A: D.100, H.228, E.233
- Ligands: FMT.34, FMT.57
Ligand excluded by PLIPFMT.34: 4 residues within 4Å:- Chain A: Q.96, D.100, E.233
- Ligands: FMT.33
Ligand excluded by PLIPFMT.35: 2 residues within 4Å:- Chain A: D.129, D.133
Ligand excluded by PLIPFMT.36: 3 residues within 4Å:- Chain A: A.137, H.138, G.139
Ligand excluded by PLIPFMT.37: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.38: 6 residues within 4Å:- Chain A: F.174, R.191, V.192, D.195
- Ligands: FMT.10, FMT.48
Ligand excluded by PLIPFMT.39: 3 residues within 4Å:- Chain A: R.343, P.345
- Ligands: FMT.55
Ligand excluded by PLIPFMT.40: 5 residues within 4Å:- Chain A: P.15, E.38, S.41, R.42
- Ligands: FMT.15
Ligand excluded by PLIPFMT.41: 4 residues within 4Å:- Chain A: E.119, P.122
- Ligands: FMT.29, FMT.62
Ligand excluded by PLIPFMT.42: 2 residues within 4Å:- Chain A: D.381, L.382
Ligand excluded by PLIPFMT.43: 3 residues within 4Å:- Chain A: A.114, Q.360
- Ligands: FMT.44
Ligand excluded by PLIPFMT.44: 5 residues within 4Å:- Chain A: R.363
- Ligands: FMT.23, FMT.43, FMT.50, FMT.58
Ligand excluded by PLIPFMT.45: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.46: 2 residues within 4Å:- Chain A: A.16
- Ligands: FMT.66
Ligand excluded by PLIPFMT.47: 1 residues within 4Å:- Chain A: T.113
Ligand excluded by PLIPFMT.48: 6 residues within 4Å:- Chain A: E.188, R.191, V.192
- Ligands: FMT.7, FMT.10, FMT.38
Ligand excluded by PLIPFMT.49: 2 residues within 4Å:- Chain A: D.224
- Ligands: FMT.64
Ligand excluded by PLIPFMT.50: 5 residues within 4Å:- Chain A: E.282, N.344, H.346
- Ligands: FMT.23, FMT.44
Ligand excluded by PLIPFMT.51: 3 residues within 4Å:- Chain A: H.351, G.352, H.355
Ligand excluded by PLIPFMT.52: 1 residues within 4Å:- Chain A: E.302
Ligand excluded by PLIPFMT.53: 3 residues within 4Å:- Chain A: Y.47, G.48, P.78
Ligand excluded by PLIPFMT.54: 1 residues within 4Å:- Chain A: E.329
Ligand excluded by PLIPFMT.55: 4 residues within 4Å:- Chain A: E.329, V.330, R.343
- Ligands: FMT.39
Ligand excluded by PLIPFMT.56: 4 residues within 4Å:- Chain A: R.42, T.51, A.52, W.53
Ligand excluded by PLIPFMT.57: 3 residues within 4Å:- Chain A: D.100, H.228
- Ligands: FMT.33
Ligand excluded by PLIPFMT.58: 1 residues within 4Å:- Ligands: FMT.44
Ligand excluded by PLIPFMT.59: 3 residues within 4Å:- Chain A: R.123
- Ligands: FMT.62, FMT.65
Ligand excluded by PLIPFMT.60: 2 residues within 4Å:- Chain A: P.18, L.21
Ligand excluded by PLIPFMT.61: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.62: 6 residues within 4Å:- Chain A: E.119, M.120, R.123
- Ligands: FMT.29, FMT.41, FMT.59
Ligand excluded by PLIPFMT.63: 1 residues within 4Å:- Chain A: E.213
Ligand excluded by PLIPFMT.64: 3 residues within 4Å:- Chain A: R.208, D.224
- Ligands: FMT.49
Ligand excluded by PLIPFMT.65: 4 residues within 4Å:- Chain A: R.123, E.159
- Ligands: FMT.24, FMT.59
Ligand excluded by PLIPFMT.66: 3 residues within 4Å:- Chain A: A.11, D.12
- Ligands: FMT.46
Ligand excluded by PLIPFMT.67: 6 residues within 4Å:- Chain A: L.27, Y.31, A.32, R.35, R.326, D.335
Ligand excluded by PLIPFMT.68: 3 residues within 4Å:- Chain A: R.191, D.195
- Ligands: FMT.10
Ligand excluded by PLIPFMT.69: 3 residues within 4Å:- Chain A: R.376, F.377, W.407
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x DEB: 6-DEOXYERYTHRONOLIDE B(Non-covalent)
- 1 x RAM: alpha-L-rhamnopyranose(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 63 x FMT: FORMIC ACID(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B